AI plays a pivotal role in revolutionising biotech within health, offering a myriad of benefits. It accelerates drug discovery by analyzing vast datasets, identifying potential compounds, and predicting their efficacy, saving time and resources.
In diagnostics, AI enhances accuracy and speed, interpreting medical images and genetic data swiftly, aiding in early disease detection and personalized treatment plans.
Moreover, AI-driven systems optimize patient care, predicting disease progression, and recommending tailored therapies, improving outcomes. Its integration empowers precision medicine, matching treatments to individual genetic profiles, enhancing efficacy, and minimizing adverse effects.
AI in biotech heralds a new era of healthcare, advancing research, diagnosis, and patient-centric approaches and ADGHW will deliver horizon scanning sessions to identify what this means for the future of the transition from healthcare to health.
Want to be part of the discussion?
www.adghw.com
Visit | Exhibit | Sponsor | Innovate
Alex Zhavoronkov, CEO of Insilico Medicine, featuring as speaker at at the Future Health Summit of Abu Dhabi Global Healthcare Week. Insilico is a biotech firm using AI for drug discovery. It has raised $400 million, chosen 11 preclinical candidates, and started human trials with an AI-discovered antifibrotic. Zhavoronkov also teaches AI at the Buck Institute and has published 160+ peer-reviewed papers and two books since 2014.
Book your delegate pass: https://bit.ly/3RsUpTS
Your journey to accelerate the future of global healthcare starts here.
#ADGHW #ADGHW2024 #AbuDhabi #DoH #FutureofHealthcare #GlobalHealthcare #AcceleratingtheFutureOfGlobalHealthcare Department of Health Abu Dhabi